Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Mr. Robert B. Ford
Full Time Employees
114,000
Sector
Healthcare
Industry
Medical - Devices
Address
100 Abbott Park Road North Chicago IL United States of America 60064-6400
IPO Date
Mar 17, 1980
Website
abbott.com
Similar Companies
Business
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Company News

  • Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

  • Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues

  • The Zacks Analyst Blog Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems

  • ABT Stock Benefits From First Patient Procedures With TAVI System

  • PAHC vs. ABT: Which Stock Is the Better Value Option?

  • Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis

  • Abbott Laboratories: Investors Should Wait For A Pullback

  • 2 Dividend Kings to Buy for a Lifetime of Passive Income

  • MACH Alliance Expands Education Program, Appoints Dylan Valade of Abbott As Head of Education

  • Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

  • Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?

  • 3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years

  • Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

  • PAHC or ABT: Which Is the Better Value Stock Right Now?

  • Abbott Laboratories Employees Credit Union ("ALECU") Data Breach - Levi & Korsinsky, LLP Launches Investigates

  • Abbott India posts Q2 profit rise on strong demand, price hikes

  • Levi & Korsinsky, LLP Investigates Abbott Laboratories Employees Credit Union ("ALECU") Data Breach

  • Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

  • Levi & Korsinsky, LLP Investigates Abbott Laboratories Employees Credit Union ("ALECU") Data Breach

  • The lawsuits against Abbott 'really steam me', says Jim Cramer